Tasly Pharmaceutical Group Co., Ltd (600535.SS) SHH

17.41

+0.36(+2.11%)

Updated at August 19 01:55PM

Currency In CNY

Valuation

Market Cap21.59B
Enterprise Value19.62B
P/E Ratio26.96
PEG Ratio17.52
Price/Sales Ratio3.1
Price/Book Ratio2.2
Enterprise/Revenue2.87
Enterprise/EBITDA18.54

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.12
Operating Margin0.14

Management Effectiveness

Return On Assets0.06
Return On Equity0.08

Income Statement

Revenue8.5B
Revenue/Share5.67
Gross Profit5.71B
EBITDA1.63B
Net Income955.59M
Diluted EPS0.64

Balance Sheet

Total Cash2.93B
Total Cash/Share1.96
Total Debt404.6M
Total Debt/Equity0.03
Current Ratio3
Book Value Per Share8.13

Price History

52-Week Change25.91
52-Week High17.77
52-Week Low13.35
Moving Average 50 Days16.05
Moving Average 200 Days15.27

Statistics

Average Volume13.75M
Shares Outstanding1.49B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.46
Trailing Annual Dividend Yield2.62
Payout Ratio1.37
Last Split Factor7:5
Last Split DateJune 05, 2018